How should refractory hyponatremia be managed in a patient with chronic kidney disease stage 5 (end‑stage renal disease)?

Hemodialysis for Refractory Hyponatremia in CKD Stage 5

For patients with CKD stage 5 and refractory hyponatremia, continuous renal replacement therapy (CRRT) with customized low-sodium replacement fluids is the preferred dialysis modality to safely correct sodium levels while managing uremia, avoiding the risk of osmotic demyelination syndrome that occurs with conventional hemodialysis.

Why CRRT Over Conventional Hemodialysis

Conventional hemodialysis poses a critical danger in severe hyponatremia because standard dialysate sodium concentrations (typically 135-145 mEq/L) will rapidly equilibrate with severely hyponatremic blood, correcting sodium too quickly and risking osmotic demyelination syndrome 1, 2. The fundamental problem is that you need to address both the uremia requiring dialysis AND the hyponatremia requiring controlled correction—these goals conflict with standard hemodialysis.

CRRT allows controlled sodium correction through:

• Customized hypotonic replacement fluids that can be adjusted daily to match the patient's current sodium level
• Slow, continuous correction preventing overcorrection (target: 4-6 mEq/L per 24 hours initially)
• Simultaneous management of hyperkalemia, metabolic acidosis, uremia, and volume overload 1, 3

Practical CRRT Management Strategy

When using continuous venovenous hemofiltration (CVVH):

1. Initial replacement fluid preparation: Start with sodium concentration 3-5 mEq/L higher than patient's current serum sodium 1, 2

2. Daily adjustments: Modify replacement fluid sodium concentration upward as serum sodium improves, maintaining controlled correction rate 1

3. Monitoring: Check serum sodium every 4-6 hours initially to ensure correction rate stays within safe limits (≤8 mEq/L per 24 hours) 3, 4

4. Single-pool sodium kinetic modeling can be used to predict and regulate the sodium correction rate precisely 2

When CRRT Is Not Available

In resource-limited settings without CRRT access, conventional hemodialysis can be modified, though this requires extreme caution 5:

• Lowest dialysate sodium: Use 128 mEq/L (minimum most machines allow)
• Reduced blood flow: Start at 50 mL/min (versus standard 300-400 mL/min)
• Short, frequent sessions: 2-3 hour sessions rather than standard 4 hours
• Gradual blood flow increases: Advance to 100 mL/min only after confirming safe correction rate (approximately 1-2 mEq/L per hour) 5

This approach successfully corrected severe hyponatremia (sodium 107-109 mEq/L) by 18 mEq/L over 48 hours without neurological complications, but requires intensive monitoring 5.

Critical Pitfalls to Avoid

Overcorrection is the primary danger: Even with CRRT, if replacement fluid sodium is too high or flow rates too aggressive, you can still correct too rapidly. The initial 24-48 hours are highest risk—patients with chronic severe hyponatremia (<120 mEq/L for >48 hours) are most vulnerable to osmotic demyelination 3, 2.

Don't use standard dialysate: Never initiate conventional hemodialysis with standard sodium dialysate (138-145 mEq/L) in patients with sodium <120 mEq/L—this will cause rapid equilibration and potential brain injury 5, 2.

Compounding errors: When preparing customized replacement fluids, pharmacy errors in sodium concentration can be catastrophic. Use standardized protocols and double-check calculations 4.

Addressing the Underlying Cause

While managing the acute hyponatremia with dialysis, identify and treat the cause of refractory hyponatremia:

• Volume status assessment: Determine if hypervolemic (common in ESRD), euvolemic (SIAD), or hypovolemic
• Medication review: Discontinue contributing agents when possible
• For SIAD in CKD patients: Consider SGLT2 inhibitors (empagliflozin) as they can normalize sodium through osmotic diuresis without proportional sodium loss, though evidence is limited to case reports 6

Long-term Dialysis Transition

Once sodium is safely corrected to >130 mEq/L and stabilized, transition to conventional hemodialysis or peritoneal dialysis can proceed with standard protocols. The KDIGO 2024 guidelines do not specifically address hyponatremia management but emphasize that patients with eGFR <15 mL/min/1.73m² require kidney replacement therapy planning 7.

The key principle: controlled, slow correction with CRRT is worth the resource investment to prevent permanent neurological damage from osmotic demyelination syndrome.